News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 317
- Sources here
- 19
- Companies here
- 17
Active search
317 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?
DexCom, Inc. DXCM is entering the second half of 2026 with healthier margins, broader reimbursement and a larger continuous glucose monitoring opportunity. The investment question is whether that improving setup is enough to justify a premium valuation. Growth catalysts remain visible across U.S. coverage, …
Elanco (ELAN) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:00 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Jeffrey SimmonsChief Financial Officer - Bob VanHimbergenVice President of Investor Relations and ESG - Tiffany KanagaInvestor Relations - Beth Haney TAKEAWAYS Total …
YPF Sociedad Anónima Q2 Earnings Call Highlights
YPF Sociedad Anónima reported record Q2 2026 profitability with adjusted EBITDA reaching $2.8 billion, driven by higher international prices and expanding shale production. The company saw a significant increase in shale oil production and raised its full-year capital expenditure outlook, with most investment directed …
Companies & Markets Analysis 12/08/2026: Hill & Smith, ECO Animal Health, Titon Holdings, CLS Holdings, Balfour Beatty, 80 Mile, Atalaya Mining Copper SA, Evoke, Seeing Machines, Kazera Global, Savannah Resources, Alternative Income REIT, Predator
MiniMed Poised to Roll Out New Innovations in Diabetes Devices but Has Yet to Dig a Moat
MiniMed, recently spun out from Medtronic, is focusing on innovation in diabetes device technology. The company, a leader in durable, tubed insulin pumps for Type 1 diabetes, faces increasing competition despite its historical market presence. An analyst note initiates coverage with a "no-moat" rating …
YPF SA (YPF) (Q2 2026) Earnings Call Highlights: Record EBITDA and Shale Output Fuel Upbeat Guidance
This article first appeared on GuruFocus. Revenue: Approximately $6.6 billion in Q2, up 33% sequentially and 42% year over year. Adjusted EBITDA: Reached $2.8 billion, a record high, up 76% sequentially and 2.5 times year over year. Adjusted EBITDA Margin: 43%, the highest level …
YPF Looks 69.3% Overvalued on GF Value™ at $49.31
YPF SA (NYSE: YPF) is deemed 69.3% overvalued according to GuruFocus's GF Value™ at a current price of $49.31, despite strong Q2 results and increased investment forecasts. The company has a GF Score™ of 80/100, indicating good financial health and momentum, though its valuation …
YPF Sociedad Anonima (YPF) Reports Q2 Earnings: What Key Metrics Have to Say
YPF Sociedad Anonima (YPF) reported $6.57 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 41.7%. EPS of $3.07 for the same period compares to $0.13 a year ago. The reported revenue represents a surprise of +8.64% over the …
Sharemaestro market context Trend signal active 52 weeks +84.9% · Next-week setup positive 55.2%Elanco's CLiK(TM) Extra (Dicyclanil Topical Suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species
Vigilance and early intervention are key to minimizing animal injury and limiting the parasite's spread, according to Elanco's technical experts Emergency Use Authorization for Elanco's CLiK Extra provides livestock producers with a vital tool in the prevention of New World screwworm infestations. Elanco also …
YPF Sociedad Anónima (NYSE:YPF) Posts Earnings Results, Misses Expectations By $1.95 EPS
YPF Sociedad Anónima (NYSE:YPF) reported quarterly earnings of $0.31 EPS, missing analyst expectations by $1.95, despite revenue of $6.57 billion exceeding estimates. The company showed a positive return on equity of 1.11% but a negative net margin of 2.16%. Insider transactions indicate purchases of …
YPF shares gain 4% after Q2 earnings and revenue beat expectations
YPF Sociedad Anónima (NYSE:YPF) shares rose 4.12% in pre-market trading after reporting second-quarter earnings and revenue that surpassed analyst expectations. The company achieved a record adjusted EBITDA of $2.80 billion, driven by higher shale production, increased refinery processing, and stronger international oil prices. YPF …
YPF SA (YPF) Shares Surge 3.6% -- What GF Score of 80 Tells Inve
YPF SA (YPF) shares surged 3.6% to $50.94, despite GuruFocus's GF Value™ indicating it is 68.8% overvalued with an estimated fair value of $30.17. The company boasts a strong GF Score™ of 80/100, driven by high growth and momentum, but shows moderate financial strength …
Insider Buying: Elanco Animal Health (NYSE:ELAN) Director Buys 10,000 Shares of Stock
Elanco Animal Health (NYSE:ELAN) Director Paul Herendeen recently purchased 10,000 shares of the company's stock for $236,800, increasing his total ownership to 111,687 shares. This insider buying follows Elanco's strong quarterly earnings report, where the company beat estimates with $0.34 EPS and saw revenue …
Phibro Animal Health CFO David Glenn Awarded 3,334 RSUs on August 6, 2026
David Glenn, CFO of Phibro Animal Health Corp (NASDAQ: PAHC), was awarded 3,334 restricted stock units (RSUs) of Class A Common Stock on August 6, 2026. The filing for this acquisition was made on August 10, 2026, with the RSUs valued at $0.
Phibro Animal Health (PAHC) awards 3,522 RSUs to Chief Operating Officer
Phibro Animal Health Corp (PAHC) has granted 3,522 restricted stock units (RSUs) to its Chief Operating Officer, Larry Lee Miller. These RSUs, representing Class A Common Stock, will vest in three equal installments over three years, contingent on his continued employment. Following this grant, …
Phibro Animal Health (PAHC) grants 2,716 RSUs to director Jonathan Bendheim
Phibro Animal Health (PAHC) director Jonathan Bendheim was granted 2,716 restricted stock units (RSUs) on August 6, 2026. These RSUs represent a contingent right to receive one share of Class A Common Stock each, and they will vest in substantially equal installments on the …
Phibro Animal Health (NASDAQ: PAHC) awards 2,478 RSUs to senior legal officer
Phibro Animal Health Corp (NASDAQ: PAHC) has awarded 2,478 Restricted Stock Units (RSUs) to Judith Weinstein, its Senior Vice President and General Counsel. This grant increases her direct holdings to 5,453 shares. The RSUs will vest in substantially equal installments over three years, beginning …
Phibro Animal Health (NASDAQ: PAHC) CFO receives 3,334-share restricted stock grant
Phibro Animal Health (NASDAQ: PAHC) CFO David Glenn was granted 3,334 restricted stock units (RSUs). These RSUs, which represent Class A Common Stock, were awarded at a price of $0.00 per share and will vest in three equal annual installments starting August 1, 2026, …
Phibro Animal Health (PAHC) awards 1,547 RSUs to SVP of Human Resources
Phibro Animal Health (PAHC) awarded 1,547 restricted stock units (RSUs) to Lisa Ann Escudero, SVP of Human Resources, on August 6, 2026. These RSUs will vest in three equal installments on the first three anniversaries of August 1, 2026, contingent on her continued employment. …
Phibro Animal Health (PAHC) grants 11,699 RSUs to President and CEO
Phibro Animal Health (PAHC) reported that its President and CEO, Daniel M. Bendheim, was granted 11,699 restricted stock units (RSUs). These RSUs represent a contingent right to receive one share of Class A Common Stock each, vesting in three equal annual installments beginning August …
Phibro Animal Health (NASDAQ: PAHC) awards 1,503 RSUs to VP Finance
Phibro Animal Health Corp (NASDAQ: PAHC) has awarded its VP Finance and Treasurer, Patrick Rodriguez, 1,503 restricted stock units (RSUs) representing Class A Common Stock. These RSUs will vest in substantially equal installments over the first three anniversaries of August 1, 2026, contingent on …
Phibro Animal Health (PAHC) grants 12,103 RSUs to Executive Chairman Bendheim
Phibro Animal Health Corp. (PAHC) Executive Chairman and 10% owner Jack Bendheim was granted 12,103 restricted stock units (RSUs). These RSUs, each representing one share of Class A Common Stock, will vest in equal installments over the first three anniversaries of August 1, 2026, …